Skip to main content
. Author manuscript; available in PMC: 2011 Jun 13.
Published in final edited form as: Am J Med Genet A. 2010 May;152A(5):1136–1156. doi: 10.1002/ajmg.a.33380

TABLE III. Summary of QoL Studies and Selected Findings1.

Genetic condition References Study population (N, age, recruit source) Study Design QoL Scale2 Selected Findings
Achondroplasia Gollust et al. 2003a,b (USA) 189 adults from support org. XS QLI Individuals with achondroplasia had globally poorer QoL than their unaffected first-degree relatives
In multivariate regression, affected status was only modestly signif. for total QoL (P= 0.039) and physical QoL (P= 0.024), and NS for the other three QoL domains
When controlling for demographics and affected status, greater perceived seriousness and lower self-esteem were strongly associated with poorer QoL in all domains
Charcot-Marie-Tooth disease Padua et al. 2008a,b (Italy) 98 adults/teens (14 y+) with CMT1A, clinic patients L(2 y) SF-36 Globally poorer QoL compared to pop. norm
QoL scores at baseline and 2 y follow-up were NS different
Clinical/neurophysiological features (e.g., ability to toe-walk, nerve conduction) associated with QoL scores in some physical health domains, few correlations with psychosocial QoL
Redmond et al. 2008 (Australia) 295 adults with CMT1A and CMT2, from support org. XS SF-36 Globally poorer QoL compared to pop. norm, NS differences in QoL between CMT types
Physical symptoms (e.g., leg weakness, cramps) associated with lower QoL in some domains
Vinci et al. 2005 (Italy) 121 adults/teens (15 y+), clinic patients XS SF-36 Globally poorer QoL compared to norm
Disease duration negatively associated with physical QoL (PCS) but not psychosocial QoL (MCS)
Teunissen et al. 2003 (The Netherlands) 43 adults/teens with CMT2, clinic patients L (5 y) SF-36 Signif. poorer QoL in most domains compared to pop. norm
In the longitudinal cohort (n = 27), NS change in any QoL domains over the 5-year period, although clinical status/disability had worsened
Congenital adrenal hyperplasia Jaaskelainen and Voutilainen 2000 (Finland) 32 adult clinic patients XS SF-36 Greater QoL in physical and psychosocial domains compared to population norms
Cystic fibrosis (CF) Gee et al. 2003, 2005, Abbott et al. 2007, 2008 (UK) 223 adult clinic patients XS CFQoL Lung function signif. associated with QoL in most domains
Coping styles: higher optimism signif. associated with higher QoL, higher distraction signif. associated with lower QoL, hopefulness and avoidance NS associated with QoL
Britto et al. 2002, 2004, Arrington-Sanders et al. 2006 (USA) 162 adults and children (5 y+), clinic patients XS SF-36 CHQ Adults (n=48) had signif. poorer physical QoL compared to pop. norm, but NS differences in psychosocial QoL domains
Among children/adolescents (n = 114), parent-rated QoL was signif. poorer in all physical domains compared to norms, but only signif. difference in psychosocial domains was for self-esteem
Lung function NS correlated with QoL, but frequency of pulmonary exacerbations was signif. associated with poorer physical QoL
Parent-rated QoL was signif. poorer than child/adolescent self-rated QoL in physical domains, but NS different for psychosocial domains
Havermans et al. 2008 (Belgium) 57 adult clinic patients XS CFQ Lung function signif. negatively associated with QoL in some physical health domains
After controlling for lung function, anxiety and depression signif. associated with 6/12 psychosocial and 3/12 physical QoL domains
Palermo et al. 2006 (USA) 46 children/adolescents (8–17 y), clinic patients XS CFQ Pain signif. associated with QoL in physical health domains, NS for emotional or social domains
Riekert et al. 2007 (USA) 76 adult clinic patients XS CFQ Depression signif. associated with poorer QoL in all domains
Szyndler et al. 2005 (Australia) 52 adolescents (12–18 y), clinic patients XS CFQ Higher levels of psychopathology and lower optimism for the future signif. associated with poorer QoL in most domains
Family functioning characteristics signif. associated with QoL in some domains
Thomas et al. 2006 (Australia) 162 children/adolescents (2–19 y), clinic patients XS PedsQL CFQ Globally poorer QoL compared to norm
Lung function signif. negatively associated with some CFQ domains, NS with any PedsQL
Darier's and Hailey–Hailey diseases Harris et al. 1996 (UK) 201 adults/teens (13 y+), clinic patients XS DLQI QoL was most negatively affected in the symptoms/feelings domain (highest score of all the domains); however, mean DLQI scores were within “small” to “moderate” effect range, indicating that the disease did not have a major negative impact on patients' QoL
NS correlation between clinical severity and QoL; NS difference in QoL between disease groups (DD vs. HHD), despite differences in symptoms
Ehlers–Danlos syndrome Berglund and Nordstrom 2001, Berglund et al. 2003 (Sweden) 77 adults from support org. XS SIP Globally poorer QoL compared to pop. norm
Greater acceptance of disability and sense of coherence signif. associated with better QoL
Fabry disease Miners et al. 2002 (UK) 38 male adult clinic patients XS SF-36 Globally poorer QoL compared to male pop. norm
Compared to patients with severe hemophilia [Miners et al., 1999], Fabry patients had signif. poorer psychosocial QoL (MCS), but physical QoL (PCS) NS different
Ries et al. 2005 (USA) 25 male children and adolescents (6–18 y), clinic patients XS CHQ Among children (n = 9), parent-rated QoL was poorer than norms in all domains, but differences were statistically signif. for two domains
Teens (n = 15, self-report) had signif. more pain (lower QoL) and better QoL in behavior, social, and emotional domains than norm
Street et al. 2006 (USA) 202 adult female heterozygotes, from support org. and clinic XS SF-36 Globally poorer QoL compared to female pop. norm
Familial dysautonomia Sands et al. 2006 (USA) 145 adults and children (4 y+), clinic patients XS SF-36 CHQ Among adults (n = 74), NS differences in QoL than pop. norm
Among children (n = 71), parent-rated QoL was signif. poorer in all physical domains and 2/4 psychosocial domains compared to norm; physical and psychosocial summary scores were also significantly poorer than children with various other chronic medical conditions
Friedrich Ataxia Epstein et al. 2008 (USA) 130 adult clinic patients XS SF-36 Compared to age/sex-matched control group and to pop. norm, patients had signif. poorer QoL in all domains except RE and MCS (NS differences)
Disease duration and clinical severity (neurological impairment) signif. associated only with PF domain; disability signif. associated with PF and GH domains
Wilson et al. 2007 (Australia) 63 adult clinic patients XS SF-36 Globally poorer QoL compared to pop. norm, physical worse than psychosocial QoL
Clinical severity (neurological impairment) signif. associated with only PF domain
After controlling for severity and disease duration, age of onset was signif. associated with QoL in some domains, with adult-onset patients having lower QoL than patients whose disease began <18 y
In multivariate regression, age of onset and severity were strongest predictors of PCS, whereas disease duration was the only factor signif. associated with MCS
Galactosemia Bosch et al. 2004 (The Netherlands) 63 adults and children (1 y+), from support org. XS TAPQoL TACQoL TAAQoL For all age groups, trend towards poorer QoL in most domains compared to healthy norms, but differences were statistically significant only in some domains (small sample sizes: n = 17 adults, n = 25 children/adolescents, n = 22 young children)
Gaucher disease Damiano et al. 1998 (USA) 212 adults/teens (14 y+) on enzyme replacement therapy, clinic patients XS SF-36 Signif. poorer QoL in physical domains compared to norm, NS differences for psychosocial domains
Ageing and clinical status (e.g., joint replacement, splenectomy) signif. associated with poorer QoL in some domains
Glycogen storage disease type 1 Storch et al. 2008 (USA) 29 children/adolescents (6–18 y), clinic patients XS PedsQL Compared to healthy control group, patients had signif. lower QoL in physical and social domains, NS differences in emotional and school domains
Compared to sample of children with various chronic medical conditions, NS differences in QoL
Hemophilia and coagulation disorders Miners et al. 1999 (UK) 164 male adult clinic patients XS SF-36 Hemophilia patients had signif. worse QoL than pop. norm in physical domains, but NS differences in psychosocial domains
Compared to patients with mild/moderate disease, patients with severe hemophilia had signif. poorer physical QoL, NS differences in psychosocial domains
Tusell et al. 2002 (Spain) 70 male adults with severe hemophilia, clinic patients XS SF-36 Signif. poorer QoL than pop. norm in all domains except mental health and emotional role-functioning
Walsh et al. 2008 (Canada) 47 male adults with mild hemophilia A from same kindred, identified through population survey XS SF-36 Compared to control cohort of unaffected age-matched male relatives, affected males had significantly poorer QoL in GH and RE domains, trend towards poorer QoL in all other domains
In multivariate regression analysis, clinical status/symptoms (heart disease and joint damage) were signif. predictors of PCS, but affected status was NS (suggests that the difference in physical QoL between hemophilia and control is largely explained by heart disease and joint damage, rather than hemophilia itself)
Solovieva 2001, Solovieva et al. 2004 (Finland) 164 adults with hemophilia, von Willebrand disease, and Factor XIII deficiency, clinic patients L(3 y) SF-36 Signif. poorer physical QoL and greater mental QoL than healthy control group
NS change in QoL in most domains between baseline and 3-year follow-up
In multivariate regression analysis, patients with severe disease and/or whose disease severity increased were more likely to have reduction in QoL over time
Hereditary hemorrhagic telangiectasia Geisthoff et al. 2007 (Germany) 77 adults/teens (13 y+), clinic patients XS SF-36 Signif. poorer QoL in all domains except pain compared to pop. norm
Clinical symptoms (e.g., epistaxis) signif. correlated with some QoL domains
Greater perceived consequences (strain on profession, private life, and psyche) and worries about HHT signif. associated with lower QoL in all domains (P < 0.05)
Pasculli et al. 2004 (Italy) 50 adult clinic patients XS SF-36 Poorer QoL in all domains except pain than pop. norm
Clinical symptoms (e.g., epistaxis) signif. associated with PCS but not MCS
Huntington disease Helder et al. 2001, 2002 (The Netherlands) 77 adults recruited from clinic and support org. XS SF-36 SIP As assessed by the SIP: QoL was globally poorer than pop. norm Psychosocial aspects impacted to a greater extent than physical aspects Cognitive/motor functioning and disease duration predicted a signif. amount of variance in physical SIP but not psychosocial SIP
As assessed by the SF-36, QoL was signif. poorer in most physical health domains, but NS differences for psychosocial domains; After controlling for demographics and illness-related variables, coping and illness perceptions predicted signif. amount of variance in QoL
Coping: “acceptance” positively associated with mental health QoL domain; venting of emotions, behavioral and mental disengagement were negatively associated with QoL
Illness identity and “cure” perceptions associated with some QoL domains
Hyperimmunoglobulinemia type D van der Hilst et al. 2008 (International) 28 adult clinic patients XS SF-36 Poorer QoL in some domains than pop. norm Symptoms (frequency of attacks) signif. associated with physical QoL, NS psychosocial QoL
Marfan syndrome Peters et al. 2002 (USA) 174 adults recruited from clinic and support org. XS QLI Individuals with Marfan syndrome had signif. poorer QoL in psychological/spiritual domain than patients with cardiovascular disease, NS difference in physical health/functioning domain
Muscular dystrophies Ahlstrom et al. 1994, Ahlstrom and Gunnarsson 1996, Ahlstrom and Sjoden Ahlstrom and Sjoden, 1996a, Natterlund et al. 2000, Bostrom et al. 2005 (Sweden) 57 adults with various MD types, identified through general population survey L (10 y) SIP Globally poorer QoL compared to pop. norm, greater impact (worst QoL) in physical dimension
NS difference in QoL between types of MD, despite differences in physical disability
Disability signif. negatively associated with physical QoL and, to a lesser extent, psychosocial QoL
Coping strategies signif. associated with psychosocial and overall QoL, NS for physical QoL
Psychosocial well-being NS correlated with QoL
QoL signif. deteriorated over the 10-year period, physical QoL to a greater extent than psychosocial QoL
Disability signif. increased over time, whereas NS change in psychosocial well-being
Piccininni et al. 2004 (Italy) 45 adults with various MD types, clinic patients XS SIP Globally poor QoL (SIP scores in “clinically-significant impairment” range), QoL in physical dimension worse than psychosocial dimension
Disability signif. negatively associated with QoL
Higher psychological well-being signif. associated with better QoL
Anxiety and depression signif. negatively correlated with QoL
Grootenhuis et al. 2007 (The Netherlands) 107 adults and children (8 y+) with various MD types, clinic patients XS TAAQoL TACQoL Children (n = 18) and adolescents (n = 22) with MD had signif. poorer QoL on some domains, but signif. better QoL in the physical functioning domains compared to healthy norms for the same age group
Adults with MD (n = 67) had signif. poorer QoL on 8/12 domains compared to healthy norms
Clinical severity signif. negatively associated with fine motor functioning and social functioning domains of QoL among adults
Antonini et al. 2006 (Italy) 20 adults with myotonic dystrophy, clinic patients XS SF-36 Globally poorer QoL compared to healthy matched controls and pop. norm
Clinical severity signif. associated with poorer QoL in physical domains, NS for psychosocial QoL
Anxiety and depressive symptoms signif. associated with poorer QoL in RP and MH domains
Ford et al. 2006 (New Zealand) 36 adults with various MD types, clinic patients XS SF-36 QoL signif. poorer in physical health domains as compared to pop. norm, NS for psychosocial QoL
NS differences between patients with myotonic dystrophy versus other MD types
Neurofibromatosis type 1 Graf et al. 2006 (Switzerland) 46 children and adolescents (7–16 y), clinic patients XS TACQoL Self-reported and proxy-reported QoL were signif. poorer than norm in the majority of domains
Clinical severity and visibility signif. associated with poorer QoL in emotional domains
Family functioning: greater cohesion and lower conflict signif. associated with better QoL when rated by parents, NS relationships with child self-reported QoL
Family history: parents with NF1 rated their children's emotional QoL lower than did parents without NF1; family history was NS associated with children's self-reported QoL
Kodra et al. 2009 (Italy) 129 adults clinic patients XS SF-36 Skindex Significantly poorer QoL in all SF-36 domains than pop. norm
Impact of NF1 on QoL was greater for psychosocial aspects than physical health aspects
Visibility signif. associated with poorer skin-specific QoL (Skindex) on all domains, but NS associated with SF-36 scores
Krab et al. 2009 (The Netherlands) 58 children and adolescents (7–17 y), clinic patients XS CHQ Parent-rated QoL was signif. poorer than pop. norm in 6/8 domains
Adolescents (n = 43 self-report) had signif. better QoL in behavior domain than norm
Severity signif. associated with some QoL domains; visibility NS associated with QoL
Oostenbrink et al. 2007 (The Netherlands) 34 young children (1–6 y), clinic patients XS ITQoL Signif. poorer QoL in some domains compared to healthy reference sample
Visibility signif. negatively associated with health perceptions domain of QoL
Page et al. 2006 (USA) 166 adults recruited from clinic and support organization XS SF-36 SkinDex Signif. poorer QoL in all SF-36 domains than population norms;
Impact of NF1 on QoL was greater for psychosocial aspects than physical health aspects
Visibility signif. associated with poorer skin-specific QoL (Skindex) on all domains, but NS associated with SF-36 scores
Clinical severity signif. associated with poorer QoL in all SF-36 domains and 2/3 Skindex domains (functioning and physical symptoms, NS emotional symptoms)
Wolkenstein et al. 2001 (France) 128 adult clinic patients XS SF-36 SkinDex Signif. poorer QoL in all SF-36 domains than population norms
Impact of NF1 on QoL was greater for psychosocial aspects than physical health aspects
Visibility signif. associated with poorer QoL on all Skindex domains and most SF-36 domains
Clinical severity signif. associated with poorer QoL in some SF-36 domains, but NS associated with Skindex scores
Wolkenstein et al. 2009 (France) 79 children and adolescents (8–16 y), clinic patients XS DISABKIDS CDLQI Using DISABKIDS, impact on total QoL was greater (i.e., worse QoL) for NF1 than for asthma
Using the CDLQI, impact on QoL was lower for NF1 (i.e., better QoL) than for other skin diseases (psoriasis, eczema, acne)
Disease complications/symptoms signif. associated with greater impact (lower QoL)
Osteogenesis imperfecta Widmann et al. 2002 (USA) 30 adult clinic patients XS SF-36 QoL signif. poorer in most physical health domains than norm, NS differences in psychosocial QoL
Phenylketonuria Landolt et al. 2002 (Switzerland) 37 children/adolescents (3–18 y) on treatment, clinic patients XS TACQoL As rated by parents, children/adolescents with PKU had signif. poorer QoL than norms in one psychosocial domain (positive emotional functioning), but NS differences in any other QoL domains
Simon et al. 2008 (Germany) 67 adult clinic patients on treatment XS PLC No signif. differences in any QoL domains compared to pop. norm
Pompe disease Hagemans et al. 2004 (International) 210 adults from support org. L (1 y) SF-36 Disability signif. associated with lower QoL in PF, SF, and RE domains
Longer disease duration signif. associated with lower PF scores, but higher RP and MH scores
Mean QoL scores for the Dutch subgroup (n = 51) were signif. lower than population norms for 3/4 physical health and 2/4 mental health domains; NS differences for BP, RE, and MH
In the Dutch cohort who were followed longitudinally (n = 38), no signif. change in QoL over the 1 y follow-up period, even among those who reported physical deterioration
Porphyria Holme et al. 2006 (UK) 220 adults and children (5 y+) with erythropoietic protoporphyria, clinic patients XS DLQI CDLQI For both adults and children, QoL was markedly impaired (mean DLQI/CDLQI scores were within the “very large effect” range)
Clinical severity signif. associated with QoL
Millward et al. 2001 (UK) 81 adults with acute porphyrias, clinic patients XS MOS Globally poorer QoL compared to pop. norm
Patients manifesting symptoms had signif. lower QoL than patients without symptoms (latent)
Patients with acute intermittent porphyria had more pain and poorer social functioning than patients with other types (variegate porphyria and hereditary coproporphyria)
Prader–Willi syndrome Caliandro et al. 2007 (Italy) 29 adults and children (5 y+), clinic patients XS SF-36 CHQ Compared to pop. norm, adults and children had signif. poorer QoL in most domains
Sickle cell disease McClish et al. 2005 (USA) 308 adult clinic patients XS SF-36 Patients with sickle cell had signif. poorer QoL in all domains except mental health, as compared to population norms and patients with cystic fibrosis
Pain signif. negatively associated with QoL in all domains except mental health
Palermo et al. 2002 (USA) 58 children/adolescents (5–18 y), clinic patients XS CHQ Globally poorer QoL than healthy controls
Disease complications negatively
associated with physical QoL, but NS with psychosocial QoL
Panepinto et al. 2005 (USA) 99 children and adolescents (5–18 y), clinic patients XS CHQ Parent-rated QoL was signif. poorer than norm in physical and psychosocial domains
Adolescents (n = 53) self-rated their QoL as signif. poorer than norms in physical domains, but NS different in psychosocial domains
QoL as rated by parents tended to be lower than adolescents' self-reported QoL
Disease complications (number of crises) was signif. negatively correlated with physical QoL
Turner syndrome Carel et al. 2005 (France) 568 adult females treated with growth hormone, clinic patients XS SF-36 NS differences in any QoL domains compared to reference sample
Psychological distress signif. correlated with lower QoL (women with symptoms of psychological distress had signif. poorer QoL in all domains than those without symptoms)
Height and other treatment-related variables NS associated with QoL
X-linked agammaglobulinemia Howard et al. 2006 (USA) 41 male adult clinic patients XS SF-12 NS differences in QoL between patients and pop norms, except GH domain
Lung disease signif. associated with lower MCS scores, but NS difference in PCS
Winkelstein et al. 2008 (USA) 25 male adult clinic patients XS SF-12 Trend towards lower QoL among patients than pop norms, but NS
1

Abbreviations used in Table III: support org., support organization; signif., significant; NS, not significant; y, years; XS, cross-sectional; L, longitudinal; pop. norm, population norm; PCS, physical component score; MCS, mental component score; PF, physical functioning; RP, role physical; BP, bodily pain; VT, vitality; MH, mental health; GH, general health perceptions; RE, role emotional; SF, social functioning.

2

See Table V QoL scale abbreviations.